Co-Authors
This is a "connection" page, showing publications co-authored by Carlo Tascini and Paolo Grossi.
Connection Strength
0.108
-
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
Score: 0.058
-
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Int J Antimicrob Agents. 2019 Apr; 53(4):408-415.
Score: 0.050